Vimarsana
Biggest News Aggregation in the World

Page 28 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

EBD Group: BIO-Europe Spring 2023 is Only a Few Weeks Away - Vimarsana News

EBD Group: BIO-Europe Spring 2023 is Only a Few Weeks Away

MUNICH, GERMANY / ACCESSWIRE / March 6, 2023 / EBD Group is thrilled to reunite on March 20-22, 2023 in Basel, Switzerland. After being held digitally for the last three years, leading executives from

EQS-News: BIO-Europe Spring® 2023 is only a few weeks away - Vimarsana News

EQS-News: BIO-Europe Spring® 2023 is only a few weeks away

EQS-News: EBD Group / Key word(s): Conference BIO-Europe Spring® 2023 is only a few weeks away 06.03.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE BIO-Europe Spring® 2023 is only a few weeks away Munich, Germany – March 6, 2023. EBD Gr...

Aiming for an Epigenetics Edge, Chroma Raises $135M to Move Closer to the Clinic - Vimarsana News

Aiming for an Epigenetics Edge, Chroma Raises $135M to Move Closer to the Clinic

GV led Chroma Medicines Series B financing round, which the biotech will apply toward epigenetic medicines that could offer advantages over other editing technologies. Other recent financings include rounds from Cargo Therapeutics and Transcend Therapeutics.

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines - Vimarsana News

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology and Expand Pipeline of Durable Precision Genomic Medicines

/PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the...

Chroma Medicine Raises $135M in Series B Financing - Vimarsana News

Chroma Medicine Raises $135M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!